Search

Your search keyword '"Miyahara, Koji"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Miyahara, Koji" Remove constraint Author: "Miyahara, Koji" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
50 results on '"Miyahara, Koji"'

Search Results

2. Association of direct oral anticoagulant and delayed bleeding with pharmacokinetics after endoscopic submucosal dissection

3. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy

6. Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)

7. Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene

11. Clinicopathological Characteristics of Superficial Barrett's Adenocarcinoma in a Japanese Population: A Retrospective, Multicenter Study

13. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas

16. Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)

17. Mo1228 ASSOCIATION OF DIRECT ORAL ANTICOAGULANT AND DELAYED BLEEDING WITH PHARMACOKINETICS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION

18. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion

22. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis

26. Clinical utility of a serum glycome analysis in patients with colorectal cancer.

27. Continued Aspirin Treatment May Be a Risk Factor of Delayed Bleeding after Gastric Endoscopic Submucosal Dissection under Heparin Replacement: A Retrospective Multicenter Study

30. Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors

36. The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer

37. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease

38. Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.

39. Su2023 Changes of Immunoglobulin-Bound Glycans in Patients With Gastro-Intestinal Cancers

40. Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

41. Utility of serum N-glycan analysis in diagnosis of invasive IPMNs

43. Prognostic Value of Altered N-Glycosylation of Circulating Glycoproteins in Patients With Unresectable Pancreatic Cancer Treated With Gemcitabine

45. Su1459 Serum N-Glycan Profiles in Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas

46. Sa1844 Alteration of Serum N-Glycan Profile in Patients With Hepatocellular Carcinoma and Their Clinical Application

48. Alteration ofN-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma

49. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion

50. Endoscopic Manifestations and Clinical Characteristics of Localized Gastric Light-Chain Amyloidosis.

Catalog

Books, media, physical & digital resources